Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.22.2.2
Stockholders’ Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Dec. 20, 2021
Jun. 21, 2022
Nov. 29, 2021
Nov. 24, 2021
Sep. 30, 2022
Jun. 21, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Stockholders’ Equity (Details) [Line Items]                  
Common shares authorized (in Shares)         500,000,000   500,000,000    
Description of authorized capital stock             The authorized capital stock is divided into: (i) 495,000,000 shares of common stock having a par value of $0.0001 per share and (ii) 5,000,000 shares of preferred stock having a par value of $0.0001 per share.    
Private placement amount                 $ 1,000,000
Sale shares (in Shares)                 625,000
Price per shares (in Dollars per share)                 $ 1.6
Shares issued (in Shares)             395,625    
Aggregate proceeds received             $ 633,000    
Issued shares (in Shares)     8,680,000            
Warrants to purchase (in Shares)     8,680,000            
Cash fee       9.00%          
Accountable expenses       $ 70,000          
Offering price per (in Dollars per share)     $ 3.5            
Aggregate gross proceeds     $ 30,380,000            
Underwriter discounts and fees     $ 27,000,000            
Warrants remain outstanding (in Shares)             8,680,000    
Weighted average remaining life             9 years 2 months 19 days    
Aggregate intrinsic value             $ 0    
Stock based compensation expense         $ 100,000   300,000 $ 30,000.00  
Remaining unamortized compensation         $ 400,000   $ 400,000    
Weighted average grant date fair value (in Dollars per share)             $ 0.45    
Volatility percentage             40.40%    
Risk-free interest rate             3.20%    
Fair value of expected term             6 years 6 months    
Stock option granted price (in Dollars per share)             $ 1    
Additional-paid-in capital and compensation expenses             $ 151,500    
Common Stock [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Shares outstanding (in Shares)         150,000   150,000    
Warrants [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Warrants to purchase (in Shares)   1,000,000       1,000,000      
Risk-free interest rate   3.38%              
Fair value of expected term   5 years              
Exercise price (in Dollars per share)           $ 1.88      
Exercisable term           5 years      
Fair value of stock price exercise price (in Dollars per share)           $ 0.35      
Fair value amount           $ 400,000      
Warrant per value (in Dollars per share)   $ 0.35       $ 0.35      
Fair value of volatility   55.70%              
Minimum [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Investors election percentage             4.99%    
Maximum [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Investors election percentage             9.99%    
Second Private Placement [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Private placement amount                 $ 5,000,000
Sale shares (in Shares)                 2,083,333
Price per shares (in Dollars per share)                 $ 2.4
Shares issued (in Shares)             239,969    
Aggregate proceeds received             $ 576,000    
Restricted Stock Units (RSUs) [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Stock based compensation expense         $ 24,000   72,000    
Remaining unamortized compensation         216,000   216,000    
Stock option granted (in Shares) 200,000                
Stock option granted price (in Dollars per share) $ 1.44                
Restricted Stock [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Stock based compensation expense         $ 20,000.00   $ 400,000    
November 2021 Private Placement [Member]                  
Stockholders’ Equity (Details) [Line Items]                  
Issued shares (in Shares)       8,680,000          
Warrants to purchase (in Shares)       8,680,000          
Purchase price (in Dollars per share)       $ 3.5          
Warrants term       5 years          
Exercise per share (in Dollars per share)       $ 3.5          
Cash fee       1.00%